JULIANNA MCCRACKEN: Open Payments
NPI 1427575570 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $141 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $53 |
| ABBVIE INC. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Janssen Biotech, Inc. | 1 | $35 |
| TerSera Therapeutics LLC | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: TECVAYLI, ELAHERE, Xermelo, Stivarga, KEYTRUDA.
Industry payments across NC — which companies pay providers there.
